544 related articles for article (PubMed ID: 33547249)
21. Screening Platforms for Genetic Epilepsies-Zebrafish, iPSC-Derived Neurons, and Organoids.
Shcheglovitov A; Peterson RT
Neurotherapeutics; 2021 Jul; 18(3):1478-1489. PubMed ID: 34595731
[TBL] [Abstract][Full Text] [Related]
22. High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.
Choo N; Ramm S; Luu J; Winter JM; Selth LA; Dwyer AR; Frydenberg M; Grummet J; Sandhu S; Hickey TE; Tilley WD; Taylor RA; Risbridger GP; Lawrence MG; Simpson KJ
SLAS Discov; 2021 Oct; 26(9):1107-1124. PubMed ID: 34111999
[TBL] [Abstract][Full Text] [Related]
23. Drug Discovery Goes Three-Dimensional: Goodbye to Flat High-Throughput Screening?
Eglen RM; Randle DH
Assay Drug Dev Technol; 2015 Jun; 13(5):262-5. PubMed ID: 26121065
[TBL] [Abstract][Full Text] [Related]
24. Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 1: Target Identification and Lead Optimization.
Eglen RM; Reisine T
SLAS Technol; 2019 Feb; 24(1):3-17. PubMed ID: 30286296
[TBL] [Abstract][Full Text] [Related]
25. Central nervous system organoids for modeling neurodegenerative diseases.
Hou PS; Kuo HC
IUBMB Life; 2022 Aug; 74(8):812-825. PubMed ID: 35102668
[TBL] [Abstract][Full Text] [Related]
26. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
[TBL] [Abstract][Full Text] [Related]
27. The future of cerebral organoids in drug discovery.
Salick MR; Lubeck E; Riesselman A; Kaykas A
Semin Cell Dev Biol; 2021 Mar; 111():67-73. PubMed ID: 32654970
[TBL] [Abstract][Full Text] [Related]
28. Neural organoids for disease phenotyping, drug screening and developmental biology studies.
Hartley BJ; Brennand KJ
Neurochem Int; 2017 Jun; 106():85-93. PubMed ID: 27744003
[TBL] [Abstract][Full Text] [Related]
29. Application of Cancer Organoid Model for Drug Screening and Personalized Therapy.
Kondo J; Inoue M
Cells; 2019 May; 8(5):. PubMed ID: 31108870
[TBL] [Abstract][Full Text] [Related]
30. Back to the origins: Human brain organoids to investigate neurodegeneration.
Faravelli I; Costamagna G; Tamanini S; Corti S
Brain Res; 2020 Jan; 1727():146561. PubMed ID: 31758922
[TBL] [Abstract][Full Text] [Related]
31. Using stem cell-derived neurons in drug screening for neurological diseases.
Little D; Ketteler R; Gissen P; Devine MJ
Neurobiol Aging; 2019 Jun; 78():130-141. PubMed ID: 30925301
[TBL] [Abstract][Full Text] [Related]
32. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids.
Schuster B; Junkin M; Kashaf SS; Romero-Calvo I; Kirby K; Matthews J; Weber CR; Rzhetsky A; White KP; Tay S
Nat Commun; 2020 Oct; 11(1):5271. PubMed ID: 33077832
[TBL] [Abstract][Full Text] [Related]
33. Organoid technology for brain and therapeutics research.
Wang Z; Wang SN; Xu TY; Miao ZW; Su DF; Miao CY
CNS Neurosci Ther; 2017 Oct; 23(10):771-778. PubMed ID: 28884977
[TBL] [Abstract][Full Text] [Related]
34. Applications of Bioengineered 3D Tissue and Tumor Organoids in Drug Development and Precision Medicine: Current and Future.
Devarasetty M; Mazzocchi AR; Skardal A
BioDrugs; 2018 Feb; 32(1):53-68. PubMed ID: 29383499
[TBL] [Abstract][Full Text] [Related]
35. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
[TBL] [Abstract][Full Text] [Related]
36. Human Cardiac Ventricular-Like Organoid Chambers and Tissue Strips From Pluripotent Stem Cells as a Two-Tiered Assay for Inotropic Responses.
Keung W; Chan PKW; Backeris PC; Lee EK; Wong N; Wong AOT; Wong GKY; Chan CWY; Fermini B; Costa KD; Li RA
Clin Pharmacol Ther; 2019 Aug; 106(2):402-414. PubMed ID: 30723889
[TBL] [Abstract][Full Text] [Related]
37. iPS cell derived neuronal cells for drug discovery.
Heilker R; Traub S; Reinhardt P; Schöler HR; Sterneckert J
Trends Pharmacol Sci; 2014 Oct; 35(10):510-9. PubMed ID: 25096281
[TBL] [Abstract][Full Text] [Related]
38. Human-cell-derived organoids as a new ex vivo model for drug assays in oncology.
Mebarki M; Bennaceur A; Bonhomme-Faivre L
Drug Discov Today; 2018 Apr; 23(4):857-863. PubMed ID: 29428171
[TBL] [Abstract][Full Text] [Related]
39. Next generation organoids for biomedical research and applications.
Lou YR; Leung AW
Biotechnol Adv; 2018; 36(1):132-149. PubMed ID: 29056474
[TBL] [Abstract][Full Text] [Related]
40. Unprecedented Potential for Neural Drug Discovery Based on Self-Organizing hiPSC Platforms.
Cota-Coronado A; Durnall JC; Díaz NF; Thompson LH; Díaz-Martínez NE
Molecules; 2020 Mar; 25(5):. PubMed ID: 32143423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
